Prosecution Insights
Prosecution Insights
3 pending office actions • 3 art units • 3 examiners • 2 of 3 (67%) have an AI response strategy ready • 5 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (33%) |
| §112 only | 1 (33%) |
| No statute on record | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DUFFY, PATRICIA ANN | 1 | 52.4% | +34.7% |
| O'BRIEN, LEA S | 1 | 50.0% | +8.3% |
| SULLIVAN, STEPHANIE LAUREN | 1 | 60.9% | +38.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17791859 | TGFB INHIBITORS AND USE THEREOF | DUFFY, PATRICIA ANN | 30d overdue |
| 17248700 | USE OF MYOSTATIN INHIBITORS AND COMBINATION THERAPIES | SULLIVAN, STEPHANIE LAUREN | 30d |
| Art Unit | Apps |
|---|---|
| 1645 | 1 |
| 1646 | 1 |
| 1635 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17791859 | TGFB INHIBITORS AND USE THEREOF | DUFFY, PATRICIA ANN | 1645 | §102 | Non-Final OA | 30d overdue | Pending | Jul 08, 2022 |
| 17758524 | TGF-BETA INHIBITORS AND USE THEREOF | O'BRIEN, LEA S | 1646 | §112 | Non-Final OA | 87d overdue | AI Ready | Jul 08, 2022 |
| 17248700 | USE OF MYOSTATIN INHIBITORS AND COMBINATION THERAPIES | SULLIVAN, STEPHANIE LAUREN | 1635 | Other | Non-Final OA | 30d | AI Ready | Feb 03, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial